Abstract:Cell cycle checkpoints, activated by stressful events, halt the cell cycle progression, and prevent the transmission of damaged DNA. These checkpoints prompt cell repair but also trigger cell death if damage persists. Decision-making between these responses is multifactorial and context-dependent, with the tumor suppressor p53 playing a central role. In many tumor cells, p53 alterations lead to G1/S checkpoint loss and the weakening of the G2 checkpoint, rendering cell viability dependent on the strength of the latter through mechanisms not fully characterized. Cells with a strong pro-survival drive can evade cell death despite substantial DNA lesions. Deciphering the integration of survival pathways with p53-dependent and -independent mechanisms governing the G2/M transition is crucial for understanding G2 arrest functionality and predicting tumor cell response to chemotherapy. The serine/threonine kinase GRK2 emerges as a signaling node in cell cycle modulation. In cycling cells, but not in G2 checkpoint-arrested cells, GRK2 protein levels decline during G2/M transition through a process triggered by CDK2-dependent phosphorylation of GRK2 at the S670 residue and Mdm2 ubiquitination. We report now that this downmodulation in G2 prevents the unscheduled activation of the PI3K/AKT pathway, allowing cells to progress into mitosis. Conversely, higher GRK2 levels lead to tyrosine phosphorylation by the kinase c-Abl, promoting the direct association of GRK2 with the p85 regulatory subunit of PI3K and AKT activation in a GRK2 catalytic-independent manner. Hyperactivation of AKT is conditioned by p53's scaffolding function, triggering FOXO3a phosphorylation, impaired Cyclin B1 accumulation, and CDK1 activation, causing a G2/M transition delay. Upon G2 checkpoint activation, GRK2 potentiates early arrest independently of p53 through AKT activation. However, its ability to overcome the G2 checkpoint in viable conditions depends on p53. Our results suggest that integrating the GRK2/PI3K/AKT axis with non-canonical functions of p53 might confer a survival advantage to tumor cells.

Reciprocal regulation of p21 and Chk1 controls the Cyclin D1-RB pathway to mediate senescence onset after DNA damage-induced G2 arrest

Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts

DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression

p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling

Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts.

PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation

SIRT1 modulates cell cycle progression by regulating CHK2 acetylation−phosphorylation

Pharmacological CDK4/6 inhibition reveals a p53‐dependent senescent state with restricted toxicity

The p21CIP1-CDK4-DREAM axis is a master regulator of genotoxic stress-induced cellular senescence

Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence.

DNA Damage Checkpoint Recovery and Cancer Development

In my end is my beginning: control of end resection and DSBR pathway ‘choice’ by cyclin-dependent kinases

Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

Akt/PKB Suppresses DNA Damage Processing and Checkpoint Activation in Late G2

GRK2-mediated AKT activation controls cell cycle progression and G2-checkpoint in a p53-dependent manner

p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53

Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence

A DNA damage checkpoint response in telomere-initiated senescence

GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner

Radiation-induced Phosphorylation of Chk1 at S345 is Associated with p53-dependent Cell Cycle Arrest Pathways

Chk1 Regulates the S Phase Checkpoint by Coupling the Physiological Turnover and Ionizing Radiation-Induced Accelerated Proteolysis of Cdc25A.